Steven Cohen’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $109M | Buy |
201,159
+51,856
| +35% | +$29.2M | 0.12% | 181 |
|
|
2026
Q1 | $88.5M | Sell |
149,303
-36,861
| -20% | -$18.4M | 0.11% | 195 |
|
|
2025
Q4 | $90.7M | Buy |
186,164
+86,380
| +87% | +$40.2M | 0.1% | 207 |
|
|
2025
Q3 | $41.8M | Buy |
+99,784
| New | +$33.6M | 0.07% | 306 |
|
|
2024
Q2 | – | Sell |
-162,700
| Closed | -$37.4M | – | 2477 |
|
|
2024
Q1 | $37.4M | Buy |
+162,700
| New | +$36.7M | 0.09% | 268 |
|
|
2023
Q4 | – | Sell |
-1,037
| Closed | -$234K | – | 2865 |
|
|
2023
Q3 | $234K | Sell |
1,037
-10,863
| -91% | -$2.5M | ﹤0.01% | 1729 |
|
|
2023
Q2 | $2.63M | Buy |
+11,900
| New | +$2.64M | 0.01% | 984 |
|
|
2022
Q3 | – | Sell |
-19,815
| Closed | -$4.67M | – | 1753 |
|
|
2022
Q2 | $4.67M | Sell |
19,815
-177,285
| -90% | -$36M | 0.02% | 725 |
|
|
2022
Q1 | $35.4M | Sell |
197,100
-10,100
| -5% | -$1.92M | 0.14% | 199 |
|
|
2021
Q4 | $44.8M | Buy |
207,200
+300
| +0.1% | +$58.9K | 0.18% | 155 |
|
|
2021
Q3 | $38.2M | Sell |
206,900
-345,500
| -63% | -$68.1M | 0.17% | 149 |
|
|
2021
Q2 | $99.1M | Buy |
+552,400
| New | +$105M | 0.45% | 41 |
|
|
2021
Q1 | – | Sell |
-343,201
| Closed | -$52.1M | – | 1188 |
|
|
2020
Q4 | $52.1M | Sell |
343,201
-97,326
| -22% | -$12.8M | 0.25% | 89 |
|
|
2020
Q3 | $44.5M | Buy |
440,527
+171,218
| +64% | +$18.8M | 0.23% | 110 |
|
|
2020
Q2 | $32.6M | Sell |
269,309
-309,839
| -53% | -$34.9M | 0.21% | 134 |
|
|
2020
Q1 | $54.9M | Buy |
+579,148
| New | +$55M | 0.45% | 51 |
|
|
2019
Q4 | – | Sell |
-640,243
| Closed | -$51.1M | – | 1266 |
|
|
2019
Q3 | $51.1M | Buy |
640,243
+180,803
| +39% | +$14.6M | 0.31% | 79 |
|
|
2019
Q2 | $35.9M | Buy |
+459,440
| New | +$43M | 0.19% | 144 |
|
|
2019
Q1 | – | Sell |
-133,643
| Closed | -$14.6M | – | 1245 |
|
|
2018
Q4 | $14.6M | Buy |
+133,643
| New | +$15.5M | 0.07% | 329 |
|
|
2018
Q3 | – | Sell |
-2,776
| Closed | -$314K | – | 1232 |
|
|
2018
Q2 | $314K | Sell |
2,776
-1,336
| -32% | -$147K | ﹤0.01% | 889 |
|
|
2018
Q1 | $462K | Sell |
4,112
-187,887
| -98% | -$23.9M | ﹤0.01% | 859 |
|
|
2017
Q4 | $28.4M | Buy |
+191,999
| New | +$24.4M | 0.12% | 229 |
|
|
2014
Q4 | – | Sell |
-8,700
| Closed | -$1.12M | – | 800 |
|
|
2014
Q3 | $1.12M | Buy |
+8,700
| New | +$897K | 0.01% | 549 |
|
Other funds holding UTHR
ACA
JT
Steven Cohen's UTHR Position: Q2 2026 in Review
Steven Cohen increased its United Therapeutics (UTHR) stake by 35% in Q2 2026, buying an estimated $29.2M and bringing the position to 201,159 shares worth $109M. The position accounts for 0.12% of the portfolio, ranked #181.
Steven Cohen first reported a position in UTHR in Q3 2014 and has held it in 23 quarters since. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Steven Cohen held 201,159 shares of United Therapeutics worth $109M as of Q2 2026.
- Steven Cohen bought 51,856 United Therapeutics shares in Q2 2026, an estimated $29.2M.
- United Therapeutics made up 0.12% of Steven Cohen's portfolio in Q2 2026, its #181 holding.
- Steven Cohen first reported a position in United Therapeutics in Q3 2014 and has held it in 23 quarters since.
- 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.